End-of-day quote
Korea S.E.
03:30:00 10/05/2024 am IST
|
5-day change
|
1st Jan Change
|
9,010
KRW
|
-1.21%
|
|
-3.53%
|
+24.45%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
23,93,411
|
12,01,906
|
4,69,045
|
2,43,124
|
Enterprise Value (EV)
1 |
23,48,548
|
10,80,523
|
4,35,468
|
1,72,948
|
P/E ratio
|
-94.2
x
|
-70.4
x
|
-13
x
|
-4.35
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
-
|
EV / Revenue
|
-
|
-
|
-
|
-
|
EV / EBITDA
|
-89.1
x
|
-39
x
|
-12.3
x
|
-6.42
x
|
EV / FCF
|
-
|
-4,60,82,764
x
|
-2,04,44,115
x
|
-84,86,721
x
|
FCF Yield
|
-
|
-0%
|
-0%
|
-0%
|
Price to Book
|
43
x
|
27.6
x
|
14.5
x
|
2.21
x
|
Nbr of stocks (in thousands)
|
20,335
|
20,510
|
21,081
|
33,581
|
Reference price
2 |
1,17,700
|
58,600
|
22,250
|
7,240
|
Announcement Date
|
14/03/22
|
14/03/22
|
13/03/23
|
20/03/24
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
-
|
-
|
-
|
EBITDA
1 |
-26,363
|
-27,736
|
-35,380
|
-26,919
|
EBIT
1 |
-27,800
|
-29,459
|
-37,246
|
-28,752
|
Operating Margin
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-25,352
|
-17,040
|
-35,753
|
-35,325
|
Net income
1 |
-25,352
|
-17,040
|
-35,753
|
-35,325
|
Net margin
|
-
|
-
|
-
|
-
|
EPS
2 |
-1,249
|
-832.3
|
-1,705
|
-1,665
|
Free Cash Flow
|
-
|
-23,447
|
-21,300
|
-20,379
|
FCF margin
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
14/03/22
|
14/03/22
|
13/03/23
|
20/03/24
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
Net Cash position
1 |
44,863
|
1,21,383
|
33,577
|
70,177
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-23,447
|
-21,300
|
-20,379
|
ROE (net income / shareholders' equity)
|
-
|
-34.3%
|
-87.2%
|
-61.1%
|
ROA (Net income/ Total Assets)
|
-
|
-19.2%
|
-19.3%
|
-19.1%
|
Assets
1 |
-
|
88,772
|
1,85,099
|
1,84,941
|
Book Value Per Share
2 |
2,740
|
2,122
|
1,533
|
3,279
|
Cash Flow per Share
2 |
132.0
|
63.00
|
17.10
|
3,358
|
Capex
1 |
718
|
757
|
878
|
101
|
Capex / Sales
|
-
|
-
|
-
|
-
|
Announcement Date
|
14/03/22
|
14/03/22
|
13/03/23
|
20/03/24
|
|
1st Jan change
|
Capi.
|
---|
| +24.45% | 221M | | +3.91% | 109B | | +10.87% | 105B | | +1.28% | 22.25B | | -13.14% | 22.09B | | -7.05% | 18.68B | | -38.36% | 17.58B | | -10.66% | 16.85B | | +3.75% | 13.76B | | +36.70% | 12.46B |
Bio Therapeutic Drugs
|